US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist

2.9400
-0.1100-3.61%

Close Sep 27 16:00 ET

35.71MMarket Cap-998P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.26%-4.89M

17.13%-4.04M

23.59%-16.43M

45.25%-4.69M

3.36%-4.88M

-14.10%-21.5M

-76.21%-8.57M

31.93%-5.05M

-11.19%-18.85M

-18.21%-5M

Net income from continuing operations

-88.95%-7.56M

-656.04%-5.57M

43.61%-10.01M

29.58%-4M

119.34%1M

-1.86%-17.75M

-30.68%-5.68M

11.34%-5.18M

-2.01%-17.42M

15.00%-5.79M

Operating gains losses

127.97%167K

93.11%-385K

-28.91%-6.85M

-1,002.66%-597K

-6,679.83%-5.58M

-2,292.55%-5.32M

23.60%-54.14K

-131.02%-82.36K

123.15%242.5K

130.44%49.21K

Depreciation and amortization

--0

1,200.00%13K

0.00%4K

6.16%1K

-0.60%1K

-3.05%4K

-10.11%942

-2.71%1.01K

-53.68%4.13K

1.00%1.01K

Other non cash items

----

--142K

----

Change In working capital

648.66%2.05M

383.84%1.6M

-205.35%-866K

87.38%-374K

-615.08%-563K

141.44%822K

-457.39%-2.96M

105.66%109.3K

-3,465.71%-1.98M

-75.28%656.9K

-Change in prepaid assets

1,980.00%564K

157.74%138K

-95.88%70K

93.56%-30K

46.03%-239K

197.52%1.7M

-450.96%-465.62K

28.99%-442.85K

-1,007.17%-1.74M

-215.98%-960.12K

-Change in payables and accrued expense

532.56%1.49M

550.62%1.46M

-6.73%-936K

86.09%-344K

-158.68%-324K

-263.43%-877K

-272.24%-2.47M

142.23%552.16K

2.57%-241.31K

-11.59%1.62M

Cash from discontinued investing activities

Operating cash flow

-4.26%-4.89M

17.13%-4.04M

23.59%-16.43M

45.25%-4.69M

3.36%-4.88M

-14.10%-21.5M

-76.21%-8.57M

31.93%-5.05M

-11.19%-18.85M

-18.21%-5M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

2,567.70%7.76M

-52.86%1.51M

-72.24%7.02M

291K

-74.03%3.21M

76.93%25.29M

12.37M

-43.00%14.29M

-81.37%1.12M

Net issuance payments of debt

--669K

---215K

----

--0

----

Net common stock issuance

2,346.21%7.09M

-46.26%1.73M

-72.15%7.02M

--290K

-74.03%3.21M

76.27%25.19M

--0

--12.37M

-42.94%14.29M

-81.37%1.12M

Proceeds from stock option exercised by employees

--0

--3K

-95.74%4K

--1K

--0

--94K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

2,567.70%7.76M

-52.86%1.51M

-72.24%7.02M

--291K

-74.03%3.21M

76.93%25.29M

--0

--12.37M

-43.00%14.29M

-81.37%1.12M

Net cash flow

Beginning cash position

-88.69%1.31M

-70.98%3.85M

41.54%13.25M

-30.74%11.58M

41.54%13.25M

-33.40%9.36M

150.78%16.72M

-33.40%9.36M

145.23%14.06M

8.71%13.39M

Current changes in cash

165.16%2.87M

-51.68%-2.53M

-348.73%-9.41M

48.65%-4.4M

-122.80%-1.67M

183.10%3.78M

-198.51%-8.57M

198.63%7.32M

-156.06%-4.55M

-320.96%-3.89M

Effect of exchange rate changes

-200.00%-2K

---5K

-93.33%7K

-16.81%2K

--0

174.61%105K

152.68%2.4K

44.45%44.38K

-170.18%-140.73K

-564.81%-142.28K

End cash Position

-41.83%4.18M

-88.69%1.31M

-70.98%3.85M

-11.90%7.18M

-30.74%11.58M

41.54%13.25M

114.98%8.15M

150.78%16.72M

-33.40%9.36M

Free cash flow

-4.26%-4.89M

17.13%-4.04M

23.59%-16.43M

45.25%-4.69M

3.36%-4.88M

-14.10%-21.5M

-76.21%-8.57M

31.93%-5.05M

-11.19%-18.85M

-18.21%-5M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.26%-4.89M	17.13%-4.04M	23.59%-16.43M	45.25%-4.69M	3.36%-4.88M	-14.10%-21.5M	-76.21%-8.57M	31.93%-5.05M	-11.19%-18.85M	-18.21%-5M
Net income from continuing operations	-88.95%-7.56M	-656.04%-5.57M	43.61%-10.01M	29.58%-4M	119.34%1M	-1.86%-17.75M	-30.68%-5.68M	11.34%-5.18M	-2.01%-17.42M	15.00%-5.79M
Operating gains losses	127.97%167K	93.11%-385K	-28.91%-6.85M	-1,002.66%-597K	-6,679.83%-5.58M	-2,292.55%-5.32M	23.60%-54.14K	-131.02%-82.36K	123.15%242.5K	130.44%49.21K
Depreciation and amortization	--0	1,200.00%13K	0.00%4K	6.16%1K	-0.60%1K	-3.05%4K	-10.11%942	-2.71%1.01K	-53.68%4.13K	1.00%1.01K
Other non cash items	----	----	--142K	----	----	----	----	----	----	----
Change In working capital	648.66%2.05M	383.84%1.6M	-205.35%-866K	87.38%-374K	-615.08%-563K	141.44%822K	-457.39%-2.96M	105.66%109.3K	-3,465.71%-1.98M	-75.28%656.9K
-Change in prepaid assets	1,980.00%564K	157.74%138K	-95.88%70K	93.56%-30K	46.03%-239K	197.52%1.7M	-450.96%-465.62K	28.99%-442.85K	-1,007.17%-1.74M	-215.98%-960.12K
-Change in payables and accrued expense	532.56%1.49M	550.62%1.46M	-6.73%-936K	86.09%-344K	-158.68%-324K	-263.43%-877K	-272.24%-2.47M	142.23%552.16K	2.57%-241.31K	-11.59%1.62M
Cash from discontinued investing activities
Operating cash flow	-4.26%-4.89M	17.13%-4.04M	23.59%-16.43M	45.25%-4.69M	3.36%-4.88M	-14.10%-21.5M	-76.21%-8.57M	31.93%-5.05M	-11.19%-18.85M	-18.21%-5M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	2,567.70%7.76M	-52.86%1.51M	-72.24%7.02M	291K	-74.03%3.21M	76.93%25.29M	0	12.37M	-43.00%14.29M	-81.37%1.12M
Net issuance payments of debt	--669K	---215K	----	--0	--0	----	----	----	----	----
Net common stock issuance	2,346.21%7.09M	-46.26%1.73M	-72.15%7.02M	--290K	-74.03%3.21M	76.27%25.19M	--0	--12.37M	-42.94%14.29M	-81.37%1.12M
Proceeds from stock option exercised by employees	--0	--3K	-95.74%4K	--1K	--0	--94K	----	----	--0	----
Cash from discontinued financing activities
Financing cash flow	2,567.70%7.76M	-52.86%1.51M	-72.24%7.02M	--291K	-74.03%3.21M	76.93%25.29M	--0	--12.37M	-43.00%14.29M	-81.37%1.12M
Net cash flow
Beginning cash position	-88.69%1.31M	-70.98%3.85M	41.54%13.25M	-30.74%11.58M	41.54%13.25M	-33.40%9.36M	150.78%16.72M	-33.40%9.36M	145.23%14.06M	8.71%13.39M
Current changes in cash	165.16%2.87M	-51.68%-2.53M	-348.73%-9.41M	48.65%-4.4M	-122.80%-1.67M	183.10%3.78M	-198.51%-8.57M	198.63%7.32M	-156.06%-4.55M	-320.96%-3.89M
Effect of exchange rate changes	-200.00%-2K	---5K	-93.33%7K	-16.81%2K	--0	174.61%105K	152.68%2.4K	44.45%44.38K	-170.18%-140.73K	-564.81%-142.28K
End cash Position	-41.83%4.18M	-88.69%1.31M	-70.98%3.85M	-11.90%7.18M	-30.74%11.58M	41.54%13.25M	114.98%8.15M	150.78%16.72M	-33.40%9.36M	-33.40%9.36M
Free cash flow	-4.26%-4.89M	17.13%-4.04M	23.59%-16.43M	45.25%-4.69M	3.36%-4.88M	-14.10%-21.5M	-76.21%-8.57M	31.93%-5.05M	-11.19%-18.85M	-18.21%-5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data